Suppr超能文献

P2X7 作为一种镇痛药物靶点的生理学、药理学和未来:炒作还是有希望?

The physiology, pharmacology and future of P2X7 as an analgesic drug target: hype or promise?

机构信息

Neuroscience, Johnson & Johnson Pharmaceutical Research & Development LLC., San Diego, CA 92121, USA.

出版信息

Curr Pharm Biotechnol. 2011 Oct;12(10):1698-706. doi: 10.2174/138920111798357429.

Abstract

P2X7 is an ATP-gated non-selective cation channel expressed primarily on cells of hematopoietic origin, such as macrophages and microglia. Since the initial cloning of this channel, enormous progress has been made in the understanding of the physiology, pharmacology and therapeutic utility of P2X7. This article attempts to review the biology of P2X7 with a focus on the complex pharmacology of this channel. Finally, the authors discuss the role of P2X7 as an analgesic drug target and raise some of the challenges and issues that face the P2X7 research community.

摘要

P2X7 是一种 ATP 门控非选择性阳离子通道,主要表达于造血细胞,如巨噬细胞和小神经胶质细胞。自该通道的最初克隆以来,人们在理解 P2X7 的生理学、药理学和治疗用途方面取得了巨大进展。本文试图通过重点介绍该通道复杂的药理学来综述 P2X7 的生物学特性。最后,作者讨论了 P2X7 作为一种镇痛药物靶点的作用,并提出了 P2X7 研究领域面临的一些挑战和问题。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验